ABOUT THE PRODUCT
Another drug candidate in preclinical development, also focused on altered cancer metabolism.
Information is owner-confirmed
Last updated 2 weeks ago
Price range
Other products/services from Cornerstone Pharmaceuticals
CPI-613 (devimistat)
Pharmaceutical
N/A
Cornerstone Pharmaceuticals
United States (US)